Literature DB >> 10811109

The Ras-mitogen-activated protein kinase pathway is critical for the activation of matrix metalloproteinase secretion and the invasiveness in v-crk-transformed 3Y1.

E Liu1, A A Thant, F Kikkawa, H Kurata, S Tanaka, A Nawa, S Mizutani, S Matsuda, H Hanafusa, M Hamaguchi.   

Abstract

To search for the intracellular signaling pathway critical for the secretion of matrix metalloproteinases (MMP), we studied the effects of dominant negative Ras (S17N Ras) and dominant negative MEK1 (MEK1AA) expression in v-crk-transformed 3Y1. Expression of either S17N Ras or MEK1AA dramatically suppressed the augmented secretion of MMP-2 and MMP-9 in v-crk-transfected 3Y1. Similarly, a Ras farnesyltransferase inhibitor, manumycin A, and a MEK1 inhibitor, U0126, suppressed MMP secretion in a dose-dependent manner, whereas a PI3 kinase inhibitor, wortmannin, could not. In addition, the suppression of MMP secretion by S17N Ras showed good correlation with the inhibition of in vitro invasiveness of the cells. In contrast, expression of dominant negative C3G did not suppress MMP secretion, although it substantially blocked the c-Jun N-terminal kinase activation. Taken together, the Ras-MEK1 pathway, but not the C3G-JNK pathway, seems to play a key role in the activation of MMP secretion and, hence, the invasiveness of v-crk-transformed cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811109

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  ERK1/2 regulate exocytosis through direct phosphorylation of the exocyst component Exo70.

Authors:  Jinqi Ren; Wei Guo
Journal:  Dev Cell       Date:  2012-05-15       Impact factor: 12.270

2.  Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma.

Authors:  Wenchao Gao; Yu Zhou; Qingyan Li; Quanbo Zhou; Langping Tan; Yadong Song; Xiaohui Zhao; Min Yu; Shangyou Zheng; Huilin Ye; Bing Zeng; Qing Lin; Jiajia Zhou; Yimin Liu; Huaiqiu Huang; Hui Zhang; Xuchu Hu; Zhihua Li; Xianhua Dai; Rufu Chen
Journal:  Diabetologia       Date:  2015-01-31       Impact factor: 10.122

3.  Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells.

Authors:  Gaurav Kaushik; Satish Ramalingam; Dharmalingam Subramaniam; Parthasarthy Rangarajan; Piero Protti; Prabhu Rammamoorthy; Shrikant Anant; Joshua M V Mammen
Journal:  Am J Surg       Date:  2012-12       Impact factor: 2.565

4.  Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide.

Authors:  Takayuki Yamaguchi; Reina Kakefuda; Atsuo Tanimoto; Yoshihiro Watanabe; Nobuyuki Tajima
Journal:  Inflamm Res       Date:  2012-01-14       Impact factor: 4.575

5.  Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner.

Authors:  Y Sohara; N Ishiguro; K Machida; H Kurata; A A Thant; T Senga; S Matsuda; K Kimata; H Iwata; M Hamaguchi
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

6.  Clustering of monosialyl-Gb5 initiates downstream signalling events leading to invasion of MCF-7 breast cancer cells.

Authors:  Severine Van Slambrouck; Wim F A Steelant
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

7.  LL-37 as a therapeutic target for late stage prostate cancer.

Authors:  Jonathan A Hensel; Diptiman Chanda; Sanjay Kumar; Anandi Sawant; William E Grizzle; Gene P Siegal; Selvarangan Ponnazhagan
Journal:  Prostate       Date:  2010-10-18       Impact factor: 4.104

8.  Protein kinase D1 inhibits cell proliferation through matrix metalloproteinase-2 and matrix metalloproteinase-9 secretion in prostate cancer.

Authors:  M Helal Uddin Biswas; Cheng Du; Chuanyou Zhang; Juerg Straubhaar; Lucia R Languino; K C Balaji
Journal:  Cancer Res       Date:  2010-02-16       Impact factor: 12.701

9.  Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis.

Authors:  Hung Huynh; Thi Thanh Tuyen Nguyen; Kah-Hoe Pierce Chow; Puay Hoon Tan; Khee Chee Soo; Evelyne Tran
Journal:  BMC Gastroenterol       Date:  2003-08-08       Impact factor: 3.067

10.  Interstitial Fluid Flow Increases Hepatocellular Carcinoma Cell Invasion through CXCR4/CXCL12 and MEK/ERK Signaling.

Authors:  Arpit D Shah; Michael J Bouchard; Adrian C Shieh
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.